Lerman Daniel A, Otero-Losada Matilde, Ume Kiddy, Salgado Pablo A, Prasad Sai, Lim Kelvin, Péault Bruno, Alotti Nasri
Department of Cardiothoracic Surgery, Royal Infirmary Hospital of Edinburgh (NHS Lothian), University of Edinburgh, Edinburgh, UK -
MRC Center for Regenerative Medicine, University of Edinburgh, Edinburgh, UK -
J Cardiovasc Surg (Torino). 2018 Feb;59(1):115-120. doi: 10.23736/S0021-9509.17.09979-7. Epub 2017 May 26.
Experimental evidence suggests that blood cardioplegia (BCP) may be superior to cold crystalloid cardioplegia (CCP) for myocardial protection. However, robust clinical data are lacking. We compared postoperative outcome of patients undergoing aortic valve replacement (AVR) using cold anterograde-retrograde intermittent BCP versus anterograde (CCP).
Adult consecutive isolated AVR performed between April 2006 and February 2011 at the Royal Infirmary Hospital of Edinburgh were retrospectively analyzed. The use of anterograde CCP was compared with that of intermittent anterograde-retrograde cold BCP. End points were intra-operative mortality, 30-day hospital re-admission, need for RBC or platelet transfusion, mechanical ventilation time and renal failure.
Of total 774 cases analyzed, 592 cases of BCP and 182 cases of CCP were identified. Demographics did not differ between groups (mean age: 67±12 years in CCP and 69±12 years in BCP). Groups (BCP vs. CCP) were indistinguishable (P>0.05, not significant) based on: average aortic cross clamp time 77.01±14.47 vs. 75.78±18.78 minutes, cardiopulmonary bypass time 104.07±43.70 vs. 100.34±25.90 minutes, surgery time 190.53±61.80 vs. 204.04±51.09 minutes and postoperative total blood consumption 1.38±2.11 vs. 1.61±2.4 units. The percentage of patients who required platelets' transfusion was similar: 12.8% BCP and 18.7% CCP (Fisher's exact test, P=0.053). Prevalence of respiratory failure was lower in BCP than in CCP: 2.6% vs. 6.3% (P=0.028). Admission time (days) at ICU was 3.63± 21.90 in BCP and 3.07±8.04 in CCP (not significant). Intra-hospital mortality, 30-day hospital re-admission, renal failure, sepsis, wound healing and stroke did not differ between groups.
BCP was strictly not superior to CCP in every aspect. In particular it was definitely not superior in terms of postoperative ventricular function. Our results question the absolute superiority of BCP over CCP in terms of hard outcomes. Likelihood of serious complications should be considered to improve risk profile of patients before choosing a cardioplegic solution.
实验证据表明,血液停搏液(BCP)在心肌保护方面可能优于冷晶体停搏液(CCP)。然而,目前缺乏有力的临床数据。我们比较了采用冷顺行 - 逆行间歇性BCP与顺行CCP进行主动脉瓣置换术(AVR)患者的术后结局。
回顾性分析2006年4月至2011年2月在爱丁堡皇家医院进行的成人连续性单纯AVR手术。将顺行CCP的使用情况与间歇性顺行 - 逆行冷BCP的使用情况进行比较。终点指标为术中死亡率、30天内再次入院率、红细胞或血小板输注需求、机械通气时间和肾衰竭。
在总共分析的774例病例中,确定了592例BCP病例和182例CCP病例。两组患者的人口统计学特征无差异(CCP组平均年龄:67±12岁,BCP组平均年龄:69±12岁)。基于以下指标,两组(BCP组与CCP组)无显著差异(P>0.05):平均主动脉阻断时间77.01±14.47分钟 vs. 75.78±18.78分钟,体外循环时间104.07±43.70分钟 vs. 100.34±25.90分钟,手术时间190.53±61.80分钟 vs. 204.04±51.09分钟,术后总失血量1.38±2.11单位 vs. 1.61±2.4单位。需要输注血小板的患者百分比相似:BCP组为12.8%,CCP组为18.7%(Fisher精确检验,P = 0.053)。BCP组呼吸衰竭的发生率低于CCP组:2.6% vs. 6.3%(P = 0.028)。BCP组在重症监护病房(ICU)的住院时间(天)为3.63±21.90天,CCP组为3.07±8.04天(无显著差异)。两组患者的院内死亡率、30天内再次入院率、肾衰竭、败血症、伤口愈合和中风情况无差异。
BCP在各方面严格来说并不优于CCP。特别是在术后心室功能方面肯定不具有优势。我们的结果对BCP在硬终点方面相对于CCP的绝对优势提出了质疑。在选择停搏液方案之前,应考虑严重并发症的可能性以改善患者的风险状况。